Skip to main content
    M

    MoonLake Immunotherapeutics (MLTX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $11.25
    -0.48 (-4.09%)

    Market Cap: $1.06B

    Last updated: Nov 17, 2026 at 4:24 PM ET

    MoonLake Immunotherapeutics (MLTX) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    MoonLake Immunotherapeutics (MLTX) has a latest price of $11.25 on Nov 17, 2026, 51.7% below its 52-week high of $23.29. Its price fell 11.9% over the past 12 months. The month-end price rose 17.8% over the 5 years through Oct 2026, a compound annual rate of 3.3%.

    Price Chart

    From Oct 2020 to Oct 2026, its highest month-end close was $60.81 in Jul 2023 and its lowest $5.25 in Jun 2022, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart MLTX with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for MLTX.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 32.8%, and over 6 months it fell 31.3%. The month-end price fell 77.3% over the 3 years through Oct 2026, a compound annual decline of 39.0%.

    PeriodChange
    1 month+15.4%
    3 months-32.8%
    6 months-31.3%
    12 months-11.9%
    12 months, with dividends-11.9%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-77.3%-39.0%
    5 years+17.8%+3.3%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2023, when the price rose 475.1%, and its weakest was 2025, when it fell 75.7%.

    YearCloseChange
    2026 through Oct 2026$11.78-10.6%
    2025$13.18-75.7%
    2024$54.15-10.3%
    2023$60.39+475.1%
    2022$10.50+6.2%
    2021$9.89-13.0%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 4.2% below its 50-day average of $11.74 and 30.6% below its 200-day average of $16.22.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$11.25
    52-week high$23.29-51.7%
    52-week low$9.46+18.9%
    50-day average$11.74-4.2%
    200-day average$16.22-30.6%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 90.2%.

    MeasureValue
    1-year beta1.62
    Largest fall, 1 year-56.9%
    Largest fall, 3 years-90.2%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About MLTX

    What is MLTX's 1-year price change?

    MoonLake Immunotherapeutics's price fell 11.9% over the past 12 months. With dividends included, the 12-month total return was -11.9%.

    What is MLTX's 5-year price change?

    MoonLake Immunotherapeutics's month-end price rose 17.8% over the 5 years through Oct 2026, a compound annual rate of 3.3%. These figures leave out dividends.

    What is MLTX's 52-week high and low?

    MoonLake Immunotherapeutics's 52-week high is $23.29 and its 52-week low is $9.46. Its latest price of $11.25 on Nov 17, 2026 is 51.7% below the high.

    What is MLTX's beta?

    MoonLake Immunotherapeutics's 1-year beta against the S&P 500 is 1.62, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 56.9%.

    Is the MLTX chart free?

    Yes. Advanced Charting for MLTX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.